UBS Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Sell |
165,718
-37,569
| -18% | -$81.9K | ﹤0.01% | 5079 |
|
|
2025
Q1 | $555K | Buy |
203,287
+92,641
| +84% | +$253K | ﹤0.01% | 4605 |
|
|
2024
Q4 | $460K | Buy |
110,646
+42,595
| +63% | +$177K | ﹤0.01% | 4750 |
|
|
2024
Q3 | $265K | Buy |
68,051
+18,449
| +37% | +$71.8K | ﹤0.01% | 4505 |
|
|
2024
Q2 | $194K | Sell |
49,602
-46,830
| -49% | -$184K | ﹤0.01% | 4559 |
|
|
2024
Q1 | $404K | Buy |
96,432
+858
| +0.9% | +$3.6K | ﹤0.01% | 4253 |
|
|
2023
Q4 | $449K | Buy |
95,574
+30,643
| +47% | +$144K | ﹤0.01% | 4047 |
|
|
2023
Q3 | $203K | Sell |
64,931
-5,986
| -8% | -$18.7K | ﹤0.01% | 4270 |
|
|
2023
Q2 | $326K | Buy |
70,917
+18,862
| +36% | +$86.6K | ﹤0.01% | 4139 |
|
|
2023
Q1 | $258K | Buy |
52,055
+8,346
| +19% | +$41.3K | ﹤0.01% | 4172 |
|
|
2022
Q4 | $239K | Buy |
43,709
+32,770
| +300% | +$179K | ﹤0.01% | 4241 |
|
|
2022
Q3 | $71K | Sell |
10,939
-8,364
| -43% | -$54.3K | ﹤0.01% | 4964 |
|
|
2022
Q2 | $91K | Buy |
19,303
+16,480
| +584% | +$77.7K | ﹤0.01% | 4507 |
|
|
2022
Q1 | $20K | Sell |
2,823
-40,892
| -94% | -$290K | ﹤0.01% | 6407 |
|
|
2021
Q4 | $445K | Buy |
43,715
+34,481
| +373% | +$351K | ﹤0.01% | 4067 |
|
|
2021
Q3 | $113K | Buy |
+9,234
| New | +$113K | ﹤0.01% | 4683 |
|